Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Amy G. Krauss"'
Autor:
Benjamin T. Duhart, Winston A. Ally, Amy G. Krauss, Joanna Q. Hudson, James D. Eason, Vinaya Rao, Jason M. Vanatta
Publikováno v:
Journal of Transplantation, Vol 2015 (2015)
Published data are limited describing renal outcomes in orthotopic liver transplant (OLT) recipients prescribed sirolimus (SRL) maintenance immunosuppression (MIS) and rabbit antithymocyte globulin (rATG) induction. We investigated whether SRL MIS an
Externí odkaz:
https://doaj.org/article/8aecdaee91eb4380af28866f45bd14f4
Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction
Publikováno v:
SAGE Open Medical Case Reports, Vol 4 (2016)
Objectives: Conversion from calcineurin inhibitor–based maintenance immunosuppression to belatacept in kidney transplant recipients has been demonstrated to improve renal function while maintaining efficacy against rejection. However, conversion st
Externí odkaz:
https://doaj.org/article/d9b87b01a26a421c89838501413b81f3
Publikováno v:
International Journal of Clinical Pharmacy. 40:1250-1256
Background Patients requiring SLED are often critically ill and/or hemodynamically unstable, and often need antibiotic therapy for life-threatening infections. Antibiotic dosing recommendations for intermittent hemodialysis and continuous renal repla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3252252526f0c13248ca55d464e999a2
https://doi.org/10.1007/s11096-018-0697-6
https://doi.org/10.1007/s11096-018-0697-6
Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction
Publikováno v:
SAGE Open Medical Case Reports, Vol 4 (2016)
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports
Objectives: Conversion from calcineurin inhibitor–based maintenance immunosuppression to belatacept in kidney transplant recipients has been demonstrated to improve renal function while maintaining efficacy against rejection. However, conversion st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2628b040496690555d1e4bc0f861fb1c
https://doaj.org/article/d9b87b01a26a421c89838501413b81f3
https://doaj.org/article/d9b87b01a26a421c89838501413b81f3
Autor:
Vivian S. Loveless, Amy G. Krauss, Joanna Q. Hudson, Lawrence J. Hak, Heather M. Owens, Jacquelyn F. Fleckenstein
Publikováno v:
Renal Failure. 35:249-256
The assessment of glomerular filtration rate (GFR) in patients with liver disease is necessary to make decisions about organ allocation. Creatinine is widely used as a marker of GFR; however, it is not reliable in patients with liver disease. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ff4c307d7c64f2ac76ada1013f5664
https://doi.org/10.3109/0886022x.2012.745786
https://doi.org/10.3109/0886022x.2012.745786
Autor:
Richard J. Knight, Wadi N. Suki, Amy G. Krauss, Benjamin Duhart, Abdul Abdellatif, A. Osama Gaber, Samir J. Patel, Saurabh Mannan, Nosratollah Nezakatgoo
Publikováno v:
Clinical Transplantation. 25:E250-E256
Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Gaber AO. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clin Transplant 2011: 25: E250–E256. © 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a482609c7ed2faf39fb2a767dce5bd48
https://doi.org/10.1111/j.1399-0012.2010.01393.x
https://doi.org/10.1111/j.1399-0012.2010.01393.x
Autor:
Amy G. Krauss, Samir J. Patel, A. Osama Gaber, Benjamin Duhart, M F Egidi, Lillian W. Gaber, Linda W. Moore, Hosein-Shokouh Amiri
Publikováno v:
Transplantation. 86:313-320
Background. Induction rabbit antithymocyte globulin (rATG) is largely used in renal allograft recipients at risk for delayed graft function (DGF) and immunologic rejection. The purpose of our study was to characterize risk factors and outcomes associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cc9af7b01c28a20de70aad9194ab1c
https://doi.org/10.1097/tp.0b013e31817ef190
https://doi.org/10.1097/tp.0b013e31817ef190
Autor:
James D. Eason, Vinaya Rao, Winston A. Ally, Benjamin Duhart, Amy G. Krauss, Joanna Q. Hudson, Jason M. Vanatta
Publikováno v:
Journal of Transplantation
Journal of Transplantation, Vol 2015 (2015)
Journal of Transplantation, Vol 2015 (2015)
Published data are limited describing renal outcomes in orthotopic liver transplant (OLT) recipients prescribed sirolimus (SRL) maintenance immunosuppression (MIS) and rabbit antithymocyte globulin (rATG) induction. We investigated whether SRL MIS an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb91c16142c1406b174d395695b90ece
http://europepmc.org/articles/PMC4377545
http://europepmc.org/articles/PMC4377545
Publikováno v:
The International journal of pharmacy practice. 21(1)
Objectives Sustained low-efficiency dialysis (SLED) is a ‘hybrid’ form of continuous renal replacement therapy; however, there is very limited information on drug disposition during this procedure. Individuals requiring SLED are often critically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b31e3bc9a5b0d153dba66b95446d01
https://pubmed.ncbi.nlm.nih.gov/23301534
https://pubmed.ncbi.nlm.nih.gov/23301534
Autor:
Samir J, Patel, Richard J, Knight, Wadi N, Suki, Abdul, Abdellatif, Benjamin T, Duhart, Amy G, Krauss, Saurabh, Mannan, Nosratollah, Nezakatgoo, A, Osama Gaber
Publikováno v:
Clinical transplantation. 25(3)
Antithymocyte globulin (rATG) is a commonly used induction agent in renal transplantation; however, data in older kidney recipients are limited.We reviewed charts of 301 deceased donor renal transplants who received a protocol consisting of 3-7 doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3bb5f93c88f1cdfb2640281a8bfdec1
https://pubmed.ncbi.nlm.nih.gov/21231963
https://pubmed.ncbi.nlm.nih.gov/21231963